Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 112

1. BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer Thyroid · 2014 · 188 citations
2. Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis Acta neuropathologica communications · 2019 · 29 citations
3. The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma Current Dermatology Reports · 2013 · 6 citations
4. 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma Journal of Investigative Dermatology · 2016
5. BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer ESMO Gastrointestinal Oncology · 2024
6. Author response: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma 2021
7. Editor's evaluation: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma 2021
8. Decision letter: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma 2021
9. 42761 The elusive BAP1 mutation in pediatric melanocytic tumors Journal of the American Academy of Dermatology · 2023
10. Author response: Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes 2020

Community

— no results